Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH 2017 | Targeting non-coding RNAs in leukemia

Ramiro Garzon • 5 Oct 2017
ESH 2017
Acute Myeloid Leukemia

There are currently several novel agents that target non-coding RNAs being tested in pre-clinical studies for the treatment of leukemia. In this video, Ramiro Garzon, MD, from the Ohio State University, Columbus, OH, discusses these exciting candidates and talks about the drug development process. This video was recorded at the International Conference on Acute Myeloid Leukaemia 2017 in Estoril, Portugal by the European School of Hematology (ESH).

More from Ramiro Garzon

2:12
Exportin (XPO1) inhibitors for the treatment of AML
Ramiro Garzon • 5 Oct 2017
1:21
Novel targets for AML
Ramiro Garzon • 5 Oct 2017

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
2:22
Haplo-SCT for older patients with AML/MDS, and should age be a barrier to transplantation?
Raynier Devillier • 15 Apr 2024
1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
The content of VJHemOnc is intended for healthcare professionals